Latest Breaking News On - Alliance management for springworks therapeutics - Page 1 : comparemela.com

NEW HAVEN, Conn., Aug. 15, 2022 (GLOBE NEWSWIRE)  Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs.

John houstonJeff boyleElisa sinclairKirsten owensExchange commissionHead of programArvinas incAlliance management for springworks therapeuticsSenior vice presidentArvinas presidentChief executiveCommercial strategyAlliance managementSpringworks therapeuticsVice presidentProject management